MX2021009855A - Roedores que tienen canales de sodio modificados geneticamente y metodos de uso de los mismos. - Google Patents

Roedores que tienen canales de sodio modificados geneticamente y metodos de uso de los mismos.

Info

Publication number
MX2021009855A
MX2021009855A MX2021009855A MX2021009855A MX2021009855A MX 2021009855 A MX2021009855 A MX 2021009855A MX 2021009855 A MX2021009855 A MX 2021009855A MX 2021009855 A MX2021009855 A MX 2021009855A MX 2021009855 A MX2021009855 A MX 2021009855A
Authority
MX
Mexico
Prior art keywords
rodents
methods
genetically modified
sodium channels
modified sodium
Prior art date
Application number
MX2021009855A
Other languages
English (en)
Inventor
Nicole Alessandri-Haber
Andrew J Murphy
Lynn Macdonald
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2021009855A publication Critical patent/MX2021009855A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

En la presente descripción se describen roedores (tales como ratones y ratas) modificados genéticamente en un locus Scn9a endógeno de modo que comprendan una secuencia de nucleótidos de Scn exógena, tal como la secuencia codificante de un gen SCN2A humano. También se describen métodos y composiciones útiles para producir tales roedores, y métodos de uso de tales roedores para generar anticuerpos anti-NaV1.7.
MX2021009855A 2019-02-22 2020-02-21 Roedores que tienen canales de sodio modificados geneticamente y metodos de uso de los mismos. MX2021009855A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962808957P 2019-02-22 2019-02-22
PCT/US2020/019171 WO2020172505A1 (en) 2019-02-22 2020-02-21 Rodents having genetically modified sodium channels and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2021009855A true MX2021009855A (es) 2021-09-10

Family

ID=70005744

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009855A MX2021009855A (es) 2019-02-22 2020-02-21 Roedores que tienen canales de sodio modificados geneticamente y metodos de uso de los mismos.

Country Status (12)

Country Link
US (1) US11464217B2 (es)
EP (1) EP3927153A1 (es)
JP (1) JP2022520819A (es)
KR (1) KR20210129083A (es)
CN (1) CN113473850A (es)
AU (1) AU2020226865A1 (es)
BR (1) BR112021016173A2 (es)
CA (1) CA3127153A1 (es)
IL (1) IL285663A (es)
MX (1) MX2021009855A (es)
SG (1) SG11202107589PA (es)
WO (1) WO2020172505A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116200472A (zh) * 2023-04-04 2023-06-02 西北农林科技大学 一种牛SCN9A基因InDel标记在肉质性状早期选择中的应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
CA2583750C (en) 2004-10-19 2015-11-24 Regeneron Pharmaceuticals, Inc. Methods for generating a rodent having a genetic modification
KR101559769B1 (ko) 2008-03-19 2015-10-13 엘지전자 주식회사 미들웨어, 녹화물 목록 제공 방법 및 녹화물 목록 제공방법을 기록한 기록매체
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
KR102178064B1 (ko) 2009-12-21 2020-11-12 리제너론 파마슈티칼스 인코포레이티드 인간화된 ＦｃγＲ 마우스
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
US20120021409A1 (en) 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130185821A1 (en) 2010-02-08 2013-07-18 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
EP2501817B2 (en) 2010-02-08 2021-04-21 Regeneron Pharmaceuticals, Inc. Common light chain mouse
US8871996B2 (en) 2010-06-09 2014-10-28 Regeneron Pharmaceuticals, Inc. Mice expressing human voltage-gated sodium channels
CN103068993B (zh) 2010-06-22 2016-01-06 瑞泽恩制药公司 杂交轻链小鼠
SG10201913160QA (en) 2011-02-25 2020-03-30 Regeneron Pharma Adam6 mice
US20130115171A1 (en) * 2011-11-09 2013-05-09 Stefan I. McDonough Nav1.7-related assays
RU2683514C2 (ru) 2012-03-06 2019-03-28 Регенерон Фармасьютикалз, Инк. Мышь с общей легкой цепью
CN104582476B (zh) 2012-06-05 2017-03-08 瑞泽恩制药公司 使用共同轻链制备完全人双特异性抗体的方法
SG10201706741VA (en) 2013-02-20 2017-10-30 Regeneron Pharma Genetic modification of rats
TR201901668T4 (tr) 2013-03-13 2019-02-21 Regeneron Pharma Sınırlı bir immünoglobulin hafif zincir repertuvarını eksprese eden fareler.
JP2016519568A (ja) 2013-03-13 2016-07-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 共通軽鎖のマウス
AU2014240392A1 (en) * 2013-03-14 2015-11-05 Regeneron Pharmaceuticals, Inc. Human antibodies to Nav1.7
PL3456831T3 (pl) 2013-04-16 2021-12-06 Regeneron Pharmaceuticals, Inc. Ukierunkowana modyfikacja genomu szczura
ES2877275T3 (es) 2014-05-30 2021-11-16 Regeneron Pharma Animales con dipeptidil peptidasa IV (DPP4) humanizada
KR20180110107A (ko) 2016-02-16 2018-10-08 리제너론 파마슈티칼스 인코포레이티드 돌연변이 키뉴레니나아제 유전자를 갖는 비인간 동물
CN109640644B (zh) * 2016-06-03 2021-10-26 瑞泽恩制药公司 表达外源末端脱氧核苷酸转移酶的非人动物
WO2017214089A1 (en) 2016-06-06 2017-12-14 Regeneron Pharmaceuticals, Inc. Non-human animals expressing antibodies with human lambda light chains
SG11201903344XA (en) 2016-11-04 2019-05-30 Regeneron Pharma Non-human animals having an engineered immunoglobulin lambda light chain locus
EP3644722A1 (en) 2017-06-27 2020-05-06 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized asgr1 locus
CA3084049A1 (en) 2017-12-05 2019-06-13 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof
MA52177A (fr) 2018-03-26 2021-02-17 Regeneron Pharma Rongeurs humanisés pour tester des agents thérapeutiques

Also Published As

Publication number Publication date
KR20210129083A (ko) 2021-10-27
AU2020226865A1 (en) 2021-07-29
BR112021016173A2 (pt) 2021-11-03
CN113473850A (zh) 2021-10-01
CA3127153A1 (en) 2020-08-27
IL285663A (en) 2021-10-31
WO2020172505A1 (en) 2020-08-27
US20200267950A1 (en) 2020-08-27
US11464217B2 (en) 2022-10-11
SG11202107589PA (en) 2021-08-30
JP2022520819A (ja) 2022-04-01
EP3927153A1 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
PH12020551317A1 (en) Anti-cd73 antibodies and methods of use thereof
EP4275698A3 (en) Anti-tigit antibodies and methods of use thereof
WO2020021045A3 (en) Therapeutic preparations of gamma-delta t cells and natural killer cells and methods for manufacture and use
HK1136847A1 (en) Targeted integration into the ppp1r12c locus
WO2020092854A3 (en) Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
PH12018500965A1 (en) Methods and compositions for gene editing in hematopoietic stem cells
MX2019012223A (es) Anticuerpos anti-cd137 y metodos de uso de los mismos.
KR20240043810A (ko) 세포 치료에 사용하기 위한 면역학적으로 식별 가능한 세포 표면 변이체
MX2021009357A (es) Dianas de genes de combinacion para mejorar la inmunoterapia.
MX2022004080A (es) Receptor de antígeno quimérico potenciado para la modificación de células efectoras inmunitarias y uso del mismo.
MX2022005815A (es) Terapia para neoplasias malignas de celulas hematopoyeticas utilizando linfocitos t modificados geneticamente que se dirigen a cd70.
PH12021550997A1 (en) Methods for making high intensity sweeteners
MX2022002613A (es) Metodos y composiciones para la integracion del genoma.
MX2022001977A (es) Poblaciones de celulas t gamma delta t ex vivo.
MX2021009855A (es) Roedores que tienen canales de sodio modificados geneticamente y metodos de uso de los mismos.
WO2020047467A3 (en) Cardiac cell reprogramming with myocardin and ascl1
PH12020550483A1 (en) Anti-apoc3 antibodies and methods of use thereof
MX2022005816A (es) Terapia de tumores solidos cd70+ utilizando linfocitos t genomodificados dirigidos a cd70.
MX2022005821A (es) Terapia del carcinoma de celulas renales (rcc) usando linfocitos t modificados por ingenieria genetica dirigidos a cd70.
JP2021508236A5 (es)
WO2023056070A3 (en) Compositions and methods for liver-specific expression of follistatin
WO2020097127A3 (en) B-cell activating cd73 antibodies
ATE532861T1 (de) Expressionsvektor
WO2022120370A3 (en) Methods of engineering immune cells for enhanced potency and persistence and uses of engineered cells in immunotherapy
ATE484576T1 (de) Chimäre bauchspeicheldrüse